Belgium· BE-AMP-SAM291697-00
Mencevax ACWY
A meningokokken a, c, y, w-135, tetravalent, gereinigtes polysaccharid-antigen product containing neisseria meningitidis a+c+w+y, purified polysaccharides, registered in Belgium by Pfizer. The same ATC class is registered in 3 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Meningokokken a, c, y, w-135, tetravalent, gereinigtes polysaccharid-antigen is registered in 3 of 19 countries.
Countries holding a registration under ATC J07AH04 (meningokokken a, c, y, w-135, tetravalent, gereinigtes polysaccharid-antigen), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 2 of them publish a price we can compare per daily dose
Meningokokken a, c, y, w-135, tetravalent, gereinigtes polysaccharid-antigen · ATC J07AH04
3 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Neisseria Meningitidis A+C+W+Y, purified Polysaccharides
- Manufacturer
- Pfizer
- Country
- Belgium (BE)
- ATC code
- J07AH04
- ATC class
- Meningokokken A, C, Y, W-135, tetravalent, gereinigtes Polysaccharid-Antigen
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb3435138
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07AH04
Meningokokken a, c, y, w-135, tetravalent, gereinigtes polysaccharid-antigen, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cd9d94f8-ff65-4843-9d72-77db657c90ce GET /v1/drugs/cd9d94f8-ff65-4843-9d72-77db657c90ce?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder and solvent for solution for injection",
"source": "afmps",
"status": "REVOKED",
"name_en": "Mencevax ACWY",
"name_fr": "Mencevax ACWY",
"name_nl": "Mencevax ACWY",
"amp_code": "SAM291697-00",
"strengths": null,
"pack_count": 1,
"substances": [
"Neisseria Meningitidis A+C+W+Y, purified Polysaccharides"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Meningococcus A,C,Y,W-135, Tetravalent Purified Polysaccharides Antigen",
"authorisation_numbers": [
"BE291697"
]
}See everything about meningokokken a, c, y, w-135, tetravalent, gereinigtes polysaccharid-antigen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.